PURETECH HEALTH PLC

PRTC
Real-time Estimate Quote. Real-time Estimate  - 08/11 05:35:49 am
226.75GBX +0.78%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
PureTech Health PLC is a clinical stage biotherapeutics company. The Company is engaged in discovering, developing and commercializing medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases, and neurological and neuropsychological disorders, among others. The Company’s pipeline is comprised of 27 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European marketing authorization. The Company’s wholly owned pipeline consists of six therapeutic candidates including LYT-100, LYT-200, LYT-210, LYT-300, LYT-500, LYT-510, and LYT-503/IMB-150. Its segments include Internal, Controlled Founded Entity, Non-Controlled Founded Entities, and Parent Company and Other. The Internal segment is advancing wholly owned programs which is focused on immunological, fibrotic and lymphatic system disorders.
Sales per Business
20202021
Internal2.8030.5%6.8254%
Controlled Founded Entities4.7752%5.6544.7%
Parent Company & Other1.6017.5%0.171.4%
GBP in Million
Sales per region
20202021
United States9.18100%12.64100%
GBP in Million
Managers
Name Title
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Operating Officer & Director
George Farmer Chief Financial Officer
Christopher A. Viehbacher Chairman
Joseph B. Bolen Chief Scientific Officer
Julie Krop Chief Medical Officer
Dame Marjorie Morris Scardino Senior Independent Non-Executive Director
Raju S. Kucherlapati Independent Non-Executive Director
John L. LaMattina Independent Non-Executive Director
Kiran Mazumdar-Shaw Independent Non-Executive Director
Shareholders
Name Equities %
Invesco Asset Management Ltd. 64,588,977 22.5%
Baillie Gifford & Co. 30,735,622 10.7%
Lansdowne Partners (UK) LLP 20,490,609 7.14%
Jupiter Asset Management Ltd. 14,247,071 4.97%
Daphne Zohar 12,564,189 4.38%
Miller Value Partners LLC 10,035,100 3.50%
M&G Investment Management Ltd. 9,687,887 3.38%
Recordati Industria Chimica e Farmaceutica S.p.A. 9,544,140 3.33%
Canaccord Genuity Wealth Ltd. 5,780,000 2.01%
Ruffer LLP 5,600,000 1.95%
Company contact information
PureTech Health Plc
6 Tide Street
Suite 400
Boston, MA 02210

Phone : +1.617.482.2333
Fax : +1.617.482.3337
Web : http://www.puretechhealth.com
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
PURETECH HEALTH PLC-14.86%784
MODERNA, INC.-31.38%68 174
LONZA GROUP AG-26.76%44 940
IQVIA HOLDINGS INC.-15.05%44 704
SEAGEN INC.13.62%32 396
ALNYLAM PHARMACEUTICALS, INC.36.81%27 846
CELLTRION, INC.6.82%22 444
ICON PUBLIC LIMITED COMPANY-21.51%19 817
BIO-TECHNE CORPORATION-26.56%14 907
HANGZHOU TIGERMED CONSULTING CO., LTD.-21.44%12 251
PHARMARON BEIJING CO., LTD.-22.52%12 228
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-39.88%11 508
QIAGEN N.V.-12.70%11 351
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.6.75%10 518
UNITED THERAPEUTICS CORPORATION2.50%10 081
GENSCRIPT BIOTECH CORPORATION-17.25%7 354
SYNEOS HEALTH, INC.-31.90%7 179
IONIS PHARMACEUTICALS, INC.51.53%6 545
CRISPR THERAPEUTICS AG4.08%6 153
GINKGO BIOWORKS HOLDINGS, INC.-62.33%5 579
JOINN LABORATORIES(CHINA)CO.,LTD.-7.94%5 562
Brand Portfolio
» More brands of PureTech Health Plc